These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

378 related articles for article (PubMed ID: 20495735)

  • 1. Matrix metalloproteinases involvement in pathologic conditions.
    Amălinei C; Căruntu ID; Giuşcă SE; Bălan RA
    Rom J Morphol Embryol; 2010; 51(2):215-28. PubMed ID: 20495735
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Extracellular matrix -- from basic research to clinical significance. An overview with special consideration of matrix metalloproteinases].
    Hamacher S; Matern S; Roeb E
    Dtsch Med Wochenschr; 2004 Sep; 129(38):1976-80. PubMed ID: 15375740
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TIMPs as multifacial proteins.
    Lambert E; Dassé E; Haye B; Petitfrère E
    Crit Rev Oncol Hematol; 2004 Mar; 49(3):187-98. PubMed ID: 15036259
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure and function of matrix metalloproteinases and TIMPs.
    Nagase H; Visse R; Murphy G
    Cardiovasc Res; 2006 Feb; 69(3):562-73. PubMed ID: 16405877
    [TBL] [Abstract][Full Text] [Related]  

  • 5. What has been learned about the cardiovascular effects of matrix metalloproteinases from mouse models?
    Janssens S; Lijnen HR
    Cardiovasc Res; 2006 Feb; 69(3):585-94. PubMed ID: 16426591
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Matrix metalloproteinases in tumour invasion and metastasis.
    Curran S; Murray GI
    J Pathol; 1999 Nov; 189(3):300-8. PubMed ID: 10547590
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Matrix metalloproteinases and atherosclerosis. Therapeutic aspects].
    Beaudeux JL; Giral P; Bruckert E; Foglietti MJ; Chapman MJ
    Ann Biol Clin (Paris); 2003; 61(2):147-58. PubMed ID: 12702469
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Matrix metalloproteinases and their inhibitors in non-neoplastic otorhinolaryngological disease.
    De S; Fenton JE; Jones AS
    J Laryngol Otol; 2005 Jun; 119(6):436-42. PubMed ID: 15992468
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Matrix metalloproteinases: contribution to pathogenesis, diagnosis, surveillance and treatment of abdominal aortic aneurysms.
    Kadoglou NP; Liapis CD
    Curr Med Res Opin; 2004 Apr; 20(4):419-32. PubMed ID: 15119978
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of matrix metalloproteinases in the oral environment.
    Hannas AR; Pereira JC; Granjeiro JM; Tjäderhane L
    Acta Odontol Scand; 2007 Feb; 65(1):1-13. PubMed ID: 17354089
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Matrix metalloproteinases: useful and deleterious.
    Ganea E; Trifan M; Laslo AC; Putina G; Cristescu C
    Biochem Soc Trans; 2007 Aug; 35(Pt 4):689-91. PubMed ID: 17635123
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Matrix metalloproteinases (MMPs) and tissue inhibitors of MMPs in the respiratory tract: potential implications in asthma and other lung diseases.
    Gueders MM; Foidart JM; Noel A; Cataldo DD
    Eur J Pharmacol; 2006 Mar; 533(1-3):133-44. PubMed ID: 16487964
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Critical appraisal of the use of matrix metalloproteinase inhibitors in cancer treatment.
    Zucker S; Cao J; Chen WT
    Oncogene; 2000 Dec; 19(56):6642-50. PubMed ID: 11426650
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Matrix metalloproteinases: their biological functions and clinical implications.
    Hijova E
    Bratisl Lek Listy; 2005; 106(3):127-32. PubMed ID: 16026148
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Matrix metalloproteinases and tissue inhibitors of metalloproteinases in the pathogenesis of rheumatoid arthritis].
    Fiedorczyk M; Klimiuk PA; Sierakowski S; Kita K
    Pol Merkur Lekarski; 2006 Feb; 20(116):228-31. PubMed ID: 16708647
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Complex roles of tissue inhibitors of metalloproteinases in cancer.
    Jiang Y; Goldberg ID; Shi YE
    Oncogene; 2002 Mar; 21(14):2245-52. PubMed ID: 11948407
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel functions of TIMPs in cell signaling.
    Chirco R; Liu XW; Jung KK; Kim HR
    Cancer Metastasis Rev; 2006 Mar; 25(1):99-113. PubMed ID: 16680576
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modifying the soil to affect the seed: role of stromal-derived matrix metalloproteinases in cancer progression.
    Jodele S; Blavier L; Yoon JM; DeClerck YA
    Cancer Metastasis Rev; 2006 Mar; 25(1):35-43. PubMed ID: 16680570
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extracellular matrix remodelling in human aortic valve disease: the role of matrix metalloproteinases and their tissue inhibitors.
    Fondard O; Detaint D; Iung B; Choqueux C; Adle-Biassette H; Jarraya M; Hvass U; Couetil JP; Henin D; Michel JB; Vahanian A; Jacob MP
    Eur Heart J; 2005 Jul; 26(13):1333-41. PubMed ID: 15827062
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathogenic role of matrix metalloproteases and their inhibitors in asthma and chronic obstructive pulmonary disease and therapeutic relevance of matrix metalloproteases inhibitors.
    Cataldo DD; Gueders MM; Rocks N; Sounni NE; Evrard B; Bartsch P; Louis R; Noel A; Foidart JM
    Cell Mol Biol (Noisy-le-grand); 2003 Sep; 49(6):875-84. PubMed ID: 14656045
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.